A long-acting subcutaneous injectable formulation of olanzapine is designed to eliminate the causes of post-injection delirium/sedation syndrome von Krtalić, I., Juretić, M., Komlosi, A., Jerbić, I. Šoljić, Prpić, M., Szabo, T., Cetina-Čižmek, B., Cherniakov, I., Wagner, A. Merenlender, Ferderber, K.

Volltext

Evaluation of the pharmacokinetics of TV-44749, newly developed once-monthly extended-release formulation of olanzapine in healthy volunteers and patients with schizophrenia von Cherniakov, I., Wagner, A. Merenlender, Elgart, A., Eshet, R., Swanson, S., Tiver, R., Bibi, D., Perlstein, I., Bilgraer, R., Kalmanczhelyi, A., Sharon, N., Ferderber, K., Vaughan, R., Gutman, D., Rabinovich-Guilatt, L.

Volltext

The Polysaccharide Capsule of Campylobacter jejuni Modulates the Host Immune Response von Maue, Alexander C, Mohawk, Krystle L, Giles, David K, Poly, Frédéric, Ewing, Cheryl P, Jiao, Yuening, Lee, Ginyoung, Ma, Zuchao, Monteiro, Mario A, Hill, Christina L, Ferderber, Jason S, Porter, Chad K, Trent, M Stephen, Guerry, Patricia

Volltext

Sports Medicine Curricular Recommendations for Undergraduate Medical Education von Ferderber, Megan, Wilson, Kristina, Buchanan, Benjamin K., Street Callender, Shelley V., Deck, Jason W., Kerr, Hamish, Lemmen, Brooke, Stafford, Cleo D., Wang, David A., Waterbrook, Anna L.

Volltext